Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Dr Reddys Laboratories Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (303)
ARTG (234)
Prescription medicine registration (15)

Date

2024 (31)
2023 (161)
2022 (28)
2021 (55)
2020 (48)
2019 (26)
2018 (52)
2017 (35)
2016 (78)
2014 (2)
2013 (9)
2012 (16)
2011 (2)
2010 (9)

Results for "[search-keyword]"

Search

Sponsor content

552 result(s) found, displaying 331 to 340

CANPEK 32/12.5 candesartan cilexetil and hydrochlorothiazide 32/12.5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2020

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
CANPEK 32/25 candesartan cilexetil and hydrochlorothiazide 32/25 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2020

Cancellation by sponsor

Requested by Dr Reddys Laboratories Australia Pty Ltd
CETRINE cetirizine hydrochloride 10 mg tablet blister pack (306826)

9 July 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for CETRINE cetirizine hydrochloride 10 mg tablet blister pack.
CARMUSTINE DR REDDY'S, CARMUSTINE-DRLA, CARMUSTINE-JUNO, REDDY'S-CARMUSTINE (Dr Reddys Laboratories Australia Pty Ltd)

14 May 2020

Prescription medicine registration

Active ingredients: carmustine.
TADALAFIL-DRLA tadalafil 10 mg film-coated tablet bottle (285615)

2 March 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for TADALAFIL-DRLA tadalafil 10 mg film-coated tablet bottle.
TADALAFIL-DRLA tadalafil 5 mg film-coated tablet bottle (285618)

2 March 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for TADALAFIL-DRLA tadalafil 5 mg film-coated tablet bottle.
TADALAFIL-RZ tadalafil 10 mg film-coated tablet bottle (285621)

2 March 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for TADALAFIL-RZ tadalafil 10 mg film-coated tablet bottle.
TADALAFIL-RZ tadalafil 2.5 mg film-coated tablet bottle (285594)

2 March 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for TADALAFIL-RZ tadalafil 2.5 mg film-coated tablet bottle.
TADALAFIL-RZ tadalafil 20 mg film-coated tablet bottle (285595)

2 March 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for TADALAFIL-RZ tadalafil 20 mg film-coated tablet bottle.
TADALAFIL-DRLA tadalafil 20 mg film-coated tablet bottle (285596)

2 March 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for TADALAFIL-DRLA tadalafil 20 mg film-coated tablet bottle.

Pages

First page
Previous page
…
Page 30
Page 31
Page 32
Page 33
Current page 34
Page 35
Page 36
Page 37
Page 38
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.